comparemela.com

Latest Breaking News On - Patrick rossignol - Page 1 : comparemela.com

Kidney Week 2023: Evolving Recognition of Cardiovascular, Kidney, and Metabolic Disease

Check out perspective from a pair of ASN Kidney Week 2023 interviews with leading trialists discussing the evolution of cardiovascular-kidney-metabolic syndrome and how pharmacotherapy has propelled the growing recognition.

United statesBoehringer ingelheim patrick rossignolRajiv agarwalPatrick rossignolChiadie ndumeleClaude roncoAmerican heart associationJohns hopkins university in baltimoreMonaco private haemodialysis centreAmerican society of nephrology kidney weekSteering committeeJournal of the american college cardiologyIndiana university school of medicineJohns hopkins universityAmerican societyNephrology kidney week

Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant

Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients

New yorkUnited statesSan franciscoDixon kaufmanPatrick rossignolDaniel brennanAmerican society of nephrology kidney weekUw health transplant centerUniversity of wisconsinAmerican societyKidney weekTherapy eases needImmunosuppressive drugs afterMedeor therapeuticsTransplant centerDiabetic kidney

Experts Perspectives: Top Story in Nephrology for 2023

At ASN Kidney Week 2023, we collected perspectives from 10 key opinion leaders in nephrology on what they see as the most significant news in their specialty from the past year.

United statesOliver grossRichard johnsonRajiv agarwalMichelle rheaultAmit gargRajnish mehrotraPatrick rossignolRichard lafayetteJonathan barrattIndiana university school of medicineGeorge institute for global healthStanford glomerular disease centerDivision of renal diseasesUniversity of coloradoUniversity of leicester

Understanding ALCHEMIST Results, with Patrick Rossignol, MD, PhD

Patrick Rossignol, MD, PhD, provides additional perspective on the results of the ALCHEMIST trial from Kidney Week 2023.

United statesPatrick rossignolZannadf massyBoehringer ingelheimMonaco private haemodialysis centreDrug administrationAmerican society of nephrology kidney weekAmerican societyNephrology kidney weekPrincess grace hospitalKidney weekAntagonist chronicInterventional survival trialPaper presented

High-impact clinical trial results to be presented at ASN Kidney Week 2023

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.

Brad rovinMichelle rheaultDanielle ellisHiddo lambers heerspinkPatrick rossignolTadao akizawaAmit gargDan brennanKatheriner tuttleUniversity of lorraineShowa university school of medicineUniversity of washingtonDrug administrationUniversity of minnesota medical schoolOhio state universityLondon health sciences centre research institute

vimarsana © 2020. All Rights Reserved.